What is Masha Mobbley's NPI number?

Masha Mobbley's National Provider Identifier (NPI) is 1063862605, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Masha Mobbley's specialty?

Masha Mobbley is listed in the NPPES registry with a primary specialty of Nurse Practitioner (Physician Assistants & Advanced Practice Nursing Providers).

Where is Masha Mobbley located?

Masha Mobbley's practice location on file with NPPES is 15906 Mill Creek Blvd, Mill Creek, WA 98012-1797.

What is Masha Mobbley's phone number?

The practice phone number listed in the NPPES registry for Masha Mobbley is (425) 385-2009.

Does Masha Mobbley accept Medicare?

Masha Mobbley is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Masha Mobbley's NPI active?

Yes — Masha Mobbley's NPI (1063862605) is active in the NPPES registry as of the last update on 2020-10-09.

IndividualActiveAccepts Medicare

Masha Mobbley, FNP

NPI 1063862605 · Nurse Practitioner · Mill Creek, WA

Masha Mobbley, FNP is a Nurse Practitioner provider in Mill Creek, WA (NPI 1063862605).

Provider details

NPI number: 1063862605
Entity type: Individual
Primary specialty: Nurse PractitionerPhysician Assistants & Advanced Practice Nursing Providers
Credential: FNP
Sex: Female
Sole proprietor: No
License: AP8761 (AZ)

Practice location

15906 Mill Creek Blvd

Mill Creek, WA 98012-1797

Phone: (425) 385-2009

Street-level locationGet directions

More WA providers

Mailing address

Po Box 24325

Seattle, WA 98124-0325

Specialties & taxonomies

Nurse PractitionerPrimary363L00000XLicense AP61090484 (WA)
Physician Assistants & Advanced Practice Nursing Providers
Nurse Practitioner363L00000XLicense AP8761 (AZ)
Physician Assistants & Advanced Practice Nursing Providers

Enrolled with Medicare as Practitioner - Nurse Practitioner · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(82/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
10 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
3,436 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	1,355	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	626	$77
Destruction of Precancer Skin Growth, 1 Growth17000	393	$45
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	216	$108
Destruction of Skin Growth, 1-14 Growths17110	195	$97
Biopsy of Related Skin Growth, First Growth

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 14 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Clobetasol Propionate	129	80
Triamcinolone Acetonide	77	51
Ketoconazole	74	51
Metronidazole	52	33
Betamethasone Dipropionate	30	19
Nystatin	29	18
Spironolactone	28	—
Doxycycline Hyclate	26

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$1,809 across 65 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2016-06-14
Last updated: 2020-10-09
Certified: 2020-10-09

Frequently asked questions

What is Masha Mobbley's NPI number?: Masha Mobbley's National Provider Identifier (NPI) is 1063862605, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Masha Mobbley's specialty?: Masha Mobbley is listed in the NPPES registry with a primary specialty of Nurse Practitioner (Physician Assistants & Advanced Practice Nursing Providers).
Where is Masha Mobbley located?: Masha Mobbley's practice location on file with NPPES is 15906 Mill Creek Blvd, Mill Creek, WA 98012-1797.
What is Masha Mobbley's phone number?: The practice phone number listed in the NPPES registry for Masha Mobbley is (425) 385-2009.
Does Masha Mobbley accept Medicare?: Masha Mobbley is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Masha Mobbley's NPI active?: Yes — Masha Mobbley's NPI (1063862605) is active in the NPPES registry as of the last update on 2020-10-09.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	1,355	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	626	$77
Destruction of Precancer Skin Growth, 1 Growth17000	393	$45
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	216	$108
Destruction of Skin Growth, 1-14 Growths17110	195	$97
Biopsy of Related Skin Growth, First Growth

Drug

Part D claims (2024)

Beneficiaries

Clobetasol Propionate

129

Triamcinolone Acetonide

Ketoconazole

Metronidazole

Betamethasone Dipropionate

Nystatin

Spironolactone

—

Doxycycline Hyclate

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$1,809 across 65 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments